BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18442742)

  • 1. Bisphosphonate related osteonecrosis of the palate: report of a case managed with free tissue transfer.
    Engroff SL; Coletti D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):580-2. PubMed ID: 18442742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws.
    Marx RE
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):107-19. PubMed ID: 19371821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bisphosphonate associated osteonecrosis of the jaws: three case reports.
    Malden NJ; Pai AY
    Br Dent J; 2007 Jul; 203(2):93-7. PubMed ID: 17660780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw.
    Wilde F; Heufelder M; Winter K; Hendricks J; Frerich B; Schramm A; Hemprich A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Feb; 111(2):153-63. PubMed ID: 20674411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-induced osteonecrosis of the jaw.
    Sharma V; Nagaraj S; Choksey U; Hegde A; Samant R; Balakrishnan C
    J Assoc Physicians India; 2011 Aug; 59():516-7. PubMed ID: 21887911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.
    Stanton DC; Balasanian E
    J Oral Maxillofac Surg; 2009 May; 67(5):943-50. PubMed ID: 19375001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
    Chiu WY; Lee JJ; Tsai KS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral bisphosphonate-related osteonecrosis of the jaws: favorable outcome after bisphosphonate holiday.
    Kwon YD; Kim YR; Choi BJ; Lee DW; Kim DY
    Quintessence Int; 2009 Apr; 40(4):277-8. PubMed ID: 19417871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers?
    Kwon YD; Ohe JY; Kim DY; Chung DJ; Park YD
    Clin Oral Implants Res; 2011 Jan; 22(1):100-5. PubMed ID: 20946206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaw and oral bisphosphonate treatment.
    Nase JB; Suzuki JB
    J Am Dent Assoc; 2006 Aug; 137(8):1115-9; quiz 1169-70. PubMed ID: 16873327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
    Pazianas M; Blumentals WA; Miller PD
    Osteoporos Int; 2008 Jun; 19(6):773-9. PubMed ID: 17999023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT; Chiang WF; Chuang CY; Chang SW
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study.
    Scoletta M; Arduino PG; Dalmasso P; Broccoletti R; Mozzati M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul; 110(1):46-53. PubMed ID: 20452252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry.
    Sedghizadeh PP; Stanley K; Caligiuri M; Hofkes S; Lowry B; Shuler CF
    J Am Dent Assoc; 2009 Jan; 140(1):61-6. PubMed ID: 19119168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important aspects concerning alendronate-related osteonecrosis of the jaws: a literature review.
    Iglesias JE; Salum FG; Figueiredo MA; Cherubini K
    Gerodontology; 2015 Sep; 32(3):169-78. PubMed ID: 24256517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical concerns of alendronate use.
    Rutkowski JL; Johnson DA; Smith DM
    J Oral Maxillofac Surg; 2007 Feb; 65(2):363-4. PubMed ID: 17236956
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports.
    Conte-Neto N; Bastos AS; Spolidorio LC; Marcantonio RA; Marcantonio E
    Head Face Med; 2011 Apr; 7():7. PubMed ID: 21524309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.